When did VERRICA PHARMACEUTICALS INC (VRCA) report earnings last quarter?
VERRICA PHARMACEUTICALS INC (VRCA) last reported earnings on 3/11/2026.
VERRICA PHARMACEUTICALS INC (VRCA) Earnings History & Surprises
NASDAQ:VRCA • US92511W2070
Current stock price
5.47 USD
-0.02 (-0.36%)
At close:
5.47 USD
0 (0%)
After Hours:
VRCA Earnings overview
Past quarterly earnings results for VERRICA PHARMACEUTICALS INC (VRCA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.48
- Revenue Estimate
- 4.692M
Last Reported
Most Recent- Release Date
- Mar 11, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.46
- EPS Surprise
- 43.23%
- Revenue Surprise
- 10.31%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.46 | -0.81 | 43.23% | 80.83% | 5.092M | 4.616M | 10.31% | 1,380.23% |
| Q3 2025 | -0.03 | -0.69 | 95.64% | 99.39% | 14.344M | 5.959M | 140.71% | 905.39% |
| Q2 2025 | 0.02 | -0.72 | 102.78% | 100.54% | 12.702M | 4.352M | 191.87% | 145.35% |
| Q1 2025 | -1.00 | -0.99 | -0.55% | 77.27% | 3.422M | 2.562M | 33.57% | -10.56% |
| Q4 2024 | -2.40 | -2.68 | 10.36% | 54.72% | 344K | 1.062M | -67.61% | -82.70% |
| Q3 2024 | -4.90 | -3.74 | -30.90% | 9.26% | -1.781M | 4.72M | -137.73% | -161.06% |
| Q2 2024 | -3.70 | -4.33 | 14.57% | -54.17% | 5.177M | 4.454M | 16.23% | 2,744.51% |
| Q1 2024 | -4.40 | -4.05 | -8.73% | -193.33% | 3.826M | 2.833M | 35.05% | 10,240.54% |
| Q4 2023 | -5.30 | -5.39 | 1.59% | -278.57% | 1.988M | 931.005K | 113.53% | 2,740.00% |
| Q3 2023 | -5.40 | -3.68 | -46.58% | -1,900.00% | 2.917M | 520.965K | 459.92% | -64.94% |
| Q2 2023 | -2.40 | -2.14 | -11.94% | 35.14% | 182K | 73.44K | 147.82% | -13.33% |
| Q1 2023 | -1.50 | -1.94 | 22.60% | 51.61% | 37K | 437.917K | -91.55% | -91.40% |
| Q4 2022 | -1.40 | -1.96 | 28.70% | 60.00% | 70K | 318.75K | -78.04% | - |
| Q3 2022 | 0.30 | -1.16 | 125.86% | 106.38% | 8.32M | 4.335M | 91.93% | - |
| Q2 2022 | -3.70 | -3.27 | -13.00% | 13.95% | 210K | 318.75K | -34.12% | - |
| Q1 2022 | -3.10 | -4.81 | 35.61% | -675.00% | 430K | 265.2K | 62.14% | -96.42% |
| Q4 2021 | -3.50 | -5.07 | 31.03% | 32.69% | - | - | ||
| Q3 2021 | -4.70 | -5.18 | 9.29% | -11.90% | - | - | ||
| Q2 2021 | -4.30 | -4.22 | -1.83% | -13.16% | 255K | -100.00% | - | |
| Q1 2021 | -0.40 | -3.54 | 88.71% | 89.74% | 12M | - | - | |
| Q4 2020 | -5.20 | -4.26 | -22.18% | - | - | - | ||
| Q3 2020 | -4.20 | -4.42 | 4.96% | - | - | - | ||
| Q2 2020 | -3.80 | -4.59 | 17.21% | - | - | - | ||
| Q1 2020 | -3.90 | -3.88 | -0.62% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
60.27%
Max EPS beat (4)
102.78%
Min EPS beat (4)
-0.55%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
94.11%
Max Revenue beat (4)
191.87%
Min Revenue beat (4)
10.31%
Analysis
In the last 4 quarters, VRCA has beaten EPS estimates in 3 out of 4 releases
VRCA has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, VRCA has beaten the EPS estimates by 60.3% on average.
In the last 4 quarters, VRCA has beaten the revenue estimates by 94.1% on average.
Related analysis
VERRICA PHARMACEUTICALS INC / VRCA Earnings FAQ
Did VERRICA PHARMACEUTICALS INC (VRCA) beat earnings estimates last quarter?
VERRICA PHARMACEUTICALS INC (VRCA) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does VRCA stock beat earnings estimates?
In the last 4 quarters, VERRICA PHARMACEUTICALS INC (VRCA) has beaten EPS estimates in 3 out of 4 releases.